Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis

CardioVascular and Interventional Radiology

Volumn 38, Issue 2, 2015, Pages 361-371

  Akinwande, Olaguoke K ^a,b   Philips, Prejesh ^c   Duras, Petr ^d   Pluntke, Stefan ^e   Scoggins, Charles ^c   Martin, Robert C G ^c  

^a UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c University of Louisville School of Medicine   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

^e KLINIKEN ESSEN MITTE   (Germany)

Author keywords

Chemoembolization; Clinical practice; Embolization; Interventional oncology; Liver

Indexed keywords

BEVACIZUMAB; IRINOTECAN; DRUG CARRIER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EMBOLIC PARTICLE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART DISEASE; HEPATIC COLORECTAL METASTASIS; HUMAN; LARGE SIZED DRUG ELUTING BEAD; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PAIN; PATIENT SELECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPENSITY SCORE; PROSPECTIVE STUDY; REGISTER; SIDE EFFECT; SMALL SIZED DRUG ELUTING BEAD; VERY ELDERLY; CHEMOEMBOLIZATION; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SECONDARY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; DRUG CARRIERS; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPENSITY SCORE; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84925518013     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-014-1011-1     Document Type: Article

References (36)

1. Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R et al (2008) Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Anticancer Res 28(6B):3835–3842 PubMed PMID: 19192637
2. Albert M, Kiefer MV, Sun W, Haller D, Fraker DL, Tuite CM et al (2011) Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 117(2):343–352. doi:10.1002/cncr.25387 PubMed PMID: 20830766
3. Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL et al (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres–safety, efficacy, and survival. Radiology 247(2):507–515. doi:10.1148/radiol.2472062029 PubMed PMID: 18349311
4. Goere D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F et al (2010) Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg 251(4):686–691. doi:10.1097/SLA.0b013e3181d35983 PubMed PMID: 20224373
5. van Hazel GA, Pavlakis N, Goldstein D, Olver IN, Tapner MJ, Price D et al (2009) Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 27(25):4089–4095. doi:10.1200/JCO.2008.20.8116 PubMed PMID: 19652069
6. Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Off J Am Soc Clin Oncol 24(9):1395–1403. doi:10.1200/JCO.2005.03.8166 PubMed PMID: 16505413
7. Bavisotto LM, Patel NH, Althaus SJ, Coldwell DM, Nghiem HV, Thompson T et al (1999) Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Clin Cancer Res Off J Am Assoc Cancer Res 5(1):95–109 PubMed PMID: 9918207
8. Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M (2007) Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 17(4):1025–1034. doi:10.1007/s00330-006-0372-5 PubMed PMID: 16944163
9. Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P et al (2012) Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res 32(4):1387–1395 PubMed PMID: 22493375
10. Martin RC, Joshi J, Robbins K, Tomalty D, Bosnjakovik P, Derner M et al (2011) Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol 18(1):192–198. doi:10.1245/s10434-010-1288-5 PubMed PMID: 20740319
11. Narayanan G, Barbery K, Suthar R, Guerrero G, Arora G (2013) Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer. Anticancer Res 33(5):2077–2083 PubMed PMID: 23645758
12. Martin R, Irurzun J, Munchart J, Trofimov I, Scupchenko A, Tatum C et al (2011) Optimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and dose. Korean J Hepatol 17(1):51–60. doi:10.3350/kjhep.2011.17.1.51 PubMed PMID: 21494078; PubMed Central PMCID: PMC3304625
13. Padia SA, Shivaram G, Bastawrous S, Bhargava P, Vo NJ, Vaidya S et al (2013) Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. J Vasc Interv Radiol JVIR 24(3):301–306. doi:10.1016/j.jvir.2012.11.023 PubMed PMID: 23380737
14. Lee KH, Liapi E, Vossen JA, Buijs M, Ventura VP, Georgiades C et al (2008) Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol JVIR 19(10):1490–1496. doi:10.1016/j.jvir.2008.06.008 PubMed PMID: 18755602; PubMed Central PMCID: PMC2747287
15. Namur J, Citron SJ, Sellers MT, Dupuis MH, Wassef M, Manfait M et al (2011) Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants. J Hepatol 55(6):1332–1338. doi:10.1016/j.jhep.2011.03.024 PubMed PMID: 21703190
16. Joffe MM, Rosenbaum PR (1999) Invited commentary: propensity scores. Am J Epidemiol 150(4):327–333 PubMed PMID: 10453808
17. Martin RC, Howard J, Tomalty D, Robbins K, Padr R, Bosnjakovic PM et al (2010) Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Interv Radiol 33(5):960–966. doi:10.1007/s00270-010-9937-4 PubMed PMID: 20661569
18. Martin RC, Joshi J, Robbins K, Tomalty D, O’Hara R, Tatum C (2009) Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): multi-institutional registry. J Oncol 2009:539795. doi:10.1155/2009/539795 PubMed PMID: 19888427; PubMed Central PMCID: PMC2771155
19. Lewandowski RJ, Wang D, Gehl J, Atassi B, Ryu RK, Sato K et al (2007) A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol JVIR 18(10):1249–1257. doi:10.1016/j.jvir.2007.06.028 PubMed PMID: 17911515
20. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25(13):1753–1759. doi:10.1200/JCO.2006.07.3049 PubMed PMID: 17470865
21. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100(10):698–711. doi:10.1093/jnci/djn134 PubMed PMID: 18477802
22. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. doi:10.1016/j.ejca.2008.10.026 PubMed PMID: 19097774
23. Haviland A, Nagin DS, Rosenbaum PR (2007) Combining propensity score matching and group-based trajectory analysis in an observational study. Psychol Methods 12(3):247–267. doi:10.1037/1082-989X.12.3.247 PubMed PMID: 17784793
24. Braitman LE, Rosenbaum PR (2002) Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med 137(8):693–695 PubMed PMID: 12379071
25. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ (2003) Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA J Am Med Assoc 290(24):3207–3214. doi:10.1001/jama.290.24.3207 PubMed PMID: 14693873
26. Poon RT, Tso WK, Pang RW, Ng KK, Woo R, Tai KS et al (2007) A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 5(9):1100–1108. doi:10.1016/j.cgh.2007.04.021 PubMed PMID: 17627902
27. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474–481. doi:10.1016/j.jhep.2006.10.020 PubMed PMID: 17239480
28. Malagari K, Chatzimichael K, Alexopoulou E, Kelekis A, Hall B, Dourakis S et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31(2):269–280. doi:10.1007/s00270-007-9226-z PubMed PMID: 17999110
29. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33(1):41–52. doi:10.1007/s00270-009-9711-7 PubMed PMID: 19908093; PubMed Central PMCID: PMC2816794
30. Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN et al (2014) Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clin Colorectal Cancer 13(1):27–36. doi:10.1016/j.clcc.2013.11.010 PubMed PMID: 24370352
31. Dreher MR, Sharma KV, Woods DL, Reddy G, Tang Y, Pritchard WF, et al. Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine. Journal of vascular and interventional radiology: JVIR. 23(2):257-64. doi:10.1016/j.jvir.2011.10.019. PubMed PMID: 22178039; PubMed Central PMCID: PMC3360470
32. Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O’Grady E et al (2014) Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. J Vasc Interv Radiol JVIR 25(3):365–369. doi:10.1016/j.jvir.2013.11.027 PubMed PMID: 24581461
33. Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127(8 Pt 2):757–763
34. Rubin DB, Thomas N (1996) Matching using estimated propensity scores: relating theory to practice. Biometrics 52(1):249–264
35. Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. New Engl J Med 342(25):1887–1892. doi:10.1056/NEJM200006223422507 PubMed PMID: 10861325; PubMed Central PMCID: PMC1557642
36. Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. New Engl J Med 342(25):1878–1886. doi:10.1056/NEJM200006223422506 PubMed PMID: 10861324